Abbott Researchers Find Rare Group of People With Controlled HIV Who Could Be a Key To Unlocking Cure

Originally published at abbott.mediaroom.com. Abbott ranked No. 8 on The DiversityInc Top 50 Companies for Diversity list in 2020.

 

Abbott announced on March 2, 2021 that a team of scientists has found an unusually high number of people in the Democratic Republic of Congo (DRC) who test positive for HIV antibodies, but have low to non-detectable viral load counts – without the use of antiretroviral treatment. These people are referred to as HIV elite controllers. These groundbreaking findings published today in EBioMedicine (part of The Lancet), may help researchers uncover biological trends within this population that could lead to advancements in HIV treatments – and potentially vaccines.

Researchers from Abbott, the Johns Hopkins University, the National Institute of Allergy and Infectious Diseases, the University of Missouri-Kansas City and the Université Protestante au Congo found that the prevalence of HIV elite controllers was 2.7-4.3% in the DRC – compared to a 0.1-2% prevalence worldwide. This new research will fuel additional studies that look to understand this unique immune response. Findings from the study could lead researchers closer to their goal of ending the HIV epidemic by uncovering links between natural virus suppression and future treatments.

“The finding of a large group of HIV elite controllers in the DRC is significant considering that HIV is a life-long, chronic condition that typically progresses over time,” said Tom Quinn, M.D., director of Johns Hopkins Center for Global Health, and chief of the International HIV/AIDS Research Section of the National Institute of Allergy and Infectious Diseases, National Institutes of Health, and one of the study authors. “There have been rare instances of the infection not progressing in individuals prior to this study, but this high frequency is unusual and suggests there is something interesting happening at a physiological level in the DRC that’s not random.”

Since the beginning of the global HIV epidemic, 76 million people have been infected with HIV and 38 million people today are living with the virus. As the first company to develop an FDA-approved test for HIV more than 30 years ago, Abbott understands the importance of HIV research and established its Global Viral Surveillance Program to identify HIV and hepatitis mutations – ensuring its diagnostic tests remain up to date. With the origins of the HIV epidemic traced to sub-Saharan Africa, specifically the DRC, this region is of specific interest to the scientific community. These new findings from Abbott researchers and partners are a continuation of virus hunting efforts that led to the identification of a new strain of HIV in 2019.

“Global surveillance work keeps us ahead of emerging infectious diseases – and in this instance, we realized we had found something that could be another step toward unlocking a cure for HIV,” said Michael Berg, Ph.D., an associate research fellow in infectious disease research at Abbott, and lead author of the study. “The global research community has more work to do – but harnessing what we learn from this study and sharing it with other researchers puts us closer to new treatments that could possibly eliminate HIV.”

Plasma samples from surveillance efforts collected in 1987, 2001-03 and 2017-19 in the DRC – home to the oldest known HIV strains – allowed researchers to rule out false positives, collection site bias, high genetic diversity and antiretroviral treatment as the cause of non-detectable viral counts in 10,457 patients from 2017 to 2019. Abbott’s ARCHITECT® HIV Ag/Ab Combo tests and m2000 real-time HIV-1 tests were used in the study to detect HIV antibodies and viral load ranges, respectively, in participants.

“Every new HIV discovery is another piece in the evolutionary jigsaw puzzle that we’re trying to understand,” said Carole McArthur, Ph.D., M.D., a professor in the department of oral and craniofacial sciences, University of Missouri-Kansas City, director of residency research in pathology, Truman Medical Center, and one of the study authors. “Each of these pieces helps us see a bit more clearly as to where we need to look next and contributes to the knowledge bank that all researchers will turn to in the next phase of our work.”

More than 25 years of hunting viruses across the globe

As a leader in blood screening and infectious disease testing, Abbott created its Global Viral Surveillance Program more than 25 years ago to monitor HIV and hepatitis viruses and identify mutations, which helps ensure the company’s diagnostic tests remain up to date. The surveillance program continues to be a pathway fueled by collaboration, enabling researchers to proactively evaluate and solve infectious disease challenges.

Abbott’s surveillance and emerging virus discovery work allowed the company to quickly respond to the COVID-19 pandemic. Abbott will increase its efforts to identify, track and prevent future pandemics across many different types of infectious diseases.

To learn more about Abbott’s virus hunting efforts, visit www.abbott.com/virushunters.

Latest News

Caron Nazario

Virginia Police Pull-Over, Threaten, and Pull Gun on Black Army Lieutenant Because They ‘Missed’ New Purchase Paperwork on Truck He Was Driving

In the latest of a seemingly never-ending stream of cases involving police racism and organizational misbehavior, two police officers in Virginia have been accused of threatening a Black Army lieutenant — and pulling a gun on him — during a routine traffic stop involving vehicle identification. David K. Li of…

Georgia voter suppression protests

More Than 100 Corporate CEOs Discuss Ways to Fight Against Georgia Voter Suppression Law

On Saturday, April 10, the CEOs from dozens of the country’s leading corporations came together on Zoom to talk about ways Corporate America can aid in the fight against a number of controversial and racist voter suppression laws that are currently in discussion across the U.S., including the new law…

moon landing

NASA Plans to Land First Person of Color and First Woman on Moon by 2024

The last manned mission to the moon took place in 1972. Forty-nine years after the Apollo program, NASA is once again talking about lunar space exploration — this time, it will have a focus on diversity and inclusion. Ashley Strickland of CNN has reported that NASA’s newly launched space program,…

student in library

Books Focusing on Race, Diversity, and Inclusion Still Labelled as “Inappropriate” for Students in 2020, American Library Association Reports

American culture as a whole experienced a civil rights reawakening throughout 2020. Although there has been a dramatic increase in calls for social justice, representation and inclusion, this progressive movement still has plenty of detractors, especially in the educational space. According to a new report from the American Library Association,…

Tishaura Jones

Tishaura Jones Becomes Mayor of St. Louis, Joins Growing Number of Black Female Mayors Leading a Major American City

More and more Black women are becoming mayors of large American cities. Tishaura Jones has become the latest in a string of recent women candidates advancing to the top of city leadership. With her win on April 6, Jones becomes the first-ever Black woman mayor of St. Louis. Formerly the…

LinkedIn

Data From 500 Million LinkedIn Accounts Hacked and Put Up for Sale on the Dark Web

In a blow to businesspeople of all levels and industries, the career and business networking site LinkedIn confirmed that data “scraped” from approximately 500 million profiles has been archived by hackers and is being sold on the dark web. The site has approximately 675 million members, meaning that data from…